NCT02199574View on ClinicalTrials.gov

Pharmacokinetic Evaluation of EXPAREL in Adults Undergoing Tonsillectomy

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

June 30, 2015

Conditions
Pain
Interventions
DRUG

EXPAREL

133 mg EXPAREL in 10 mL.

Trial Locations (2)

77024

Memorial Hermann - Memorial City Medical Center, Houston

Memorial Village Surgery Center, Houston

Sponsors
All Listed Sponsors
lead

Pacira Pharmaceuticals, Inc

INDUSTRY

NCT02199574 - Pharmacokinetic Evaluation of EXPAREL in Adults Undergoing Tonsillectomy | Biotech Hunter | Biotech Hunter